Live Quote · NASDAQCMPSHealthcare· Medical - Care Facilities

COMPASS Pathways plc

$13.62 2.48%(+$0.33)
TickerSpark Score
58/100
Mixed
73
Valuation
20
Profitability
15
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CMPS research report →

52-Week Range85% of range
Low
$3.24
Current
$13.62
High
$15.40
Company Overviewcompasspathways.com

About the company

COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy.

CEO
Kabir Kumar Nath
IPO
2020
Employees
166
HQ
London, GB

Price Chart

+302.96% · this period
$15.07$9.16$3.26Jul 02Dec 31Jul 02
Valuation
Market Cap
$1.31B
P/E
-6.33
P/S
0.00
P/B
4.59
EV/EBITDA
-4.79
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-150.89%
ROIC
-44.64%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-287,862,000 · -85.57%
EPS
$-3.08 · -33.91%
Op Income
$-179,037,000
FCF YoY
-31.93%
Performance & Tape
52W High
$15.40
52W Low
$3.24
50D MA
$11.34
200D MA
$7.58
Beta
2.51
Avg Volume
4.40M

Get TickerSpark's AI analysis on CMPS

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
May 27, 26Karydas Daphneother21,110
May 27, 26SANTINI GINOother30,158
May 27, 26Gover Justin D.other21,110
May 27, 26JONAS JEFFREY Mother21,110
May 27, 26Riley Wayne Josephother21,110
May 27, 26McQuade Robertother21,110
May 27, 26Norton David Yother21,110
May 27, 26Tregoning Kathleenother41,119
May 27, 26Tregoning Kathleenother0
Mar 26, 26Nath Kabirother367,815
Coverage · CMPS

Our CMPS coverage

Recent articles, reports, and earnings notes.

View all →
For Active Investors

Want a deeper read on CMPS?

Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.

Generate CMPS report →
Internal Compare

Similar companies

Peers in the same neighborhood.